Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Metronidazole

Metronidazole: 29 brands, 62 generics; first approved Mar 04, 1982; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 62 ANDA applications approved.

Earliest patent expiry
Brands (NDA)
29
Generics (ANDA)
62
Listed patents
9
Next patent expiry
Feb 02, 2028
in 1 yr 4 mo

Brand (NDA) products

Originator applications
  • LIKMEZRLDRS
    NDA 2167552023
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/5MLSUSPENSIONORALRx—
  • NUVESSARLDRS
    NDA 2052232014
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1.3%GELVAGINALRx—
  • NDA 0217892005
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%GELTOPICALRxAB
  • NDA 0209011998
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%LOTIONTOPICALRxAB
  • NDA 0208681997
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    750MGTABLET, EXTENDED RELEASEORALDiscontinued—
  • NDA 0207431997
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%CREAMTOPICALRx—
  • NDA 0205311995
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%CREAMTOPICALRxAB
  • FLAGYLRLDRS
    NDA 0203341995
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    375MGCAPSULEORALRxAB
  • NDA 0202081992
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALDiscontinued—
  • NDA 0197371988
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELTOPICALDiscontinued—
  • NDA 0188901983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONRxAP
  • NDA 0189001983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • NDA 018657—
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONRxAP
  • NDA 012623—2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • NDA 0218062005
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALRxBX
  • METRONIDAZOLE
    NDA 0190291984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    NDA 0189071984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    NDA 0188891983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    NDA 0188451983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    NDA 0189301983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGTABLETORALDiscontinued—
  • NDA 01887119832 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    NDA 01881819832 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    NDA 01874019822 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    NDA 01859919822 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    NDA 01876419822 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • NDA 0186741982
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    NDA 01862019822 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    NDA 018517—2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—

Generic (ANDA) products (62)

Abbreviated applications
  • METRONIDAZOLE
    ANDA 2200952026
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 2192952025
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%CREAMTOPICALRxAB
  • METRONIDAZOLE
    ANDA 2167502024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALRxAB
  • METRONIDAZOLE
    ANDA 07077220243 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
    125MGTABLETORALRx—
  • METRONIDAZOLE
    ANDA 2189412024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 2167952024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1.3%GELVAGINALDiscontinued—
  • METRONIDAZOLE
    ANDA 2163232023
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALRxAB
  • METRONIDAZOLERS
    ANDA 2156102023
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALRxAB
  • Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONRxAP
  • METRONIDAZOLE
    ANDA 2171282023
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%CREAMTOPICALRxBX
  • METRONIDAZOLE
    ANDA 2166922023
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 2157942022
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALRxAB
  • METRONIDAZOLE
    ANDA 2136482021
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALRxAB
  • METRONIDAZOLE
    ANDA 2126462021
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%GELTOPICALRxAB
  • Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONRxAP
  • METRONIDAZOLE
    ANDA 2117862019
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALRxAB
  • ANDA 2061912019
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONRxAP
  • METRONIDAZOLE
    ANDA 20979420172 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 20909620172 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 20868120172 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    ANDA 2046512017
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 20656020162 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 20816220162 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 20730920162 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 20524520152 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 20397420152 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 20345820142 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 0909032011
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%GELTOPICALDiscontinued—
  • METRONIDAZOLERS
    ANDA 0781782011
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 0902222010
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    750MGTABLET, EXTENDED RELEASEORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0790652009
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    375MGCAPSULEORALRxAB
  • METRONIDAZOLE
    ANDA 07906720092 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
    500MGTABLETORALRxAB
  • ANDA 0780842008
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    ANDA 0775492007
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%CREAMTOPICALRxAB
  • METRONIDAZOLE
    ANDA 0772642006
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELVAGINALDiscontinued—
  • METRONIDAZOLE
    ANDA 0778192006
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 0775472006
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 0770182006
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%GELTOPICALRxAB
  • METRONIDAZOLE
    ANDA 0771972006
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%LOTIONTOPICALRxAB
  • METRONIDAZOLERS
    ANDA 0764082004
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.75%CREAMTOPICALRxAB
  • METRONIDAZOLE
    ANDA 0765222004
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    375MGCAPSULEORALRxAB
  • METRONIDAZOLE
    ANDA 0765052003
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    375MGCAPSULEORALDiscontinued—
  • METRONIDAZOLE
    ANDA 07651920032 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0764622003
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    750MGTABLET, EXTENDED RELEASEORALDiscontinued—
  • ANDA 07452319962 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
    500MGTABLETORALDiscontinued—
  • ANDA 0707311987
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0701701986
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    ANDA 0705931986
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0700041985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    ANDA 0700211985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
  • ANDA 0700291985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0700441985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 0700401985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0700391985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0700421984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    ANDA 0700351984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 0700081984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0700091984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGTABLETORALDiscontinued—
  • METRONIDAZOLE
    ANDA 0700331984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGTABLETORALRxAB
  • METRONIDAZOLE
    ANDA 0700711984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MG/100MLINJECTABLEINJECTIONDiscontinued—
  • METRONIDAZOLE
    ANDA 0700271984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGTABLETORALRxAB

Patent & exclusivity timeline

Protection horizon
20262028203020322034203620382040TodayPatent 8877792: 2028-02-02Patent 8877792Patent 7893097: 2028-02-19Patent 7893097Patent 8658678: 2028-06-27Patent 8658678Patent 9198858: 2032-06-28Patent 9198858Patent 8946276: 2032-06-28Patent 8946276Patent 10238634: 2032-06-28Patent 10238634Patent 10596155: 2032-06-28Patent 10596155Patent 12257236: 2039-01-16Patent 12257236Patent 11541035: 2039-10-04Patent 11541035
Patent expiryExclusivity endToday

Listed patents

Orange Book patent file
Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8877792in 1 yr 4 mo
Product
7893097in 1 yr 5 mo
Product
8658678in 1 yr 9 mo
U-1682
9198858in 5 yr 10 mo
U-1664
8946276in 5 yr 10 mo
U-1664
10238634in 5 yr 10 mo
Product
10596155in 5 yr 10 mo
Product
12257236in 12 yr 5 mo
ProductU-3169
11541035in 13 yr 2 mo
Product

Approval history

FDA approval span
First approval
45 yr 3 mo ago
Most recent approval
8 mo ago

Approvals span 1982–2026 across 91 FDA applications.

Brand (NDA) 2932%
Generic (ANDA) 6268%

Metronidazole: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.